Evaluation of Rational Use of Linezolid in Hospitalized Patient in Shahid Chamran Hospital in Isfahan City during the Second Six Months of the 2021

Fatemeh Bandegani, G. Afzal, Mehrnoush Dianatkhah, S. Sohrevardi
{"title":"Evaluation of Rational Use of Linezolid in Hospitalized Patient in Shahid Chamran Hospital in Isfahan City during the Second Six Months of the 2021","authors":"Fatemeh Bandegani, G. Afzal, Mehrnoush Dianatkhah, S. Sohrevardi","doi":"10.18502/ssu.v31i9.14186","DOIUrl":null,"url":null,"abstract":"Introduction: The rational use of drugs is one of the main elements of achieving the best pharmacotherapy method for patients. Linezolid is used for infections caused by gram-positive bacteria, including vancomycin-resistant staphylococci and vancomycin-resistant enterococci, but the inappropriate use of this drug has led to the emergence of linezolid-resistant strains. The purpose of this study was to investigate the manner of Linezolid prescription in Shahid Chamran Hospital of Isfahan City in 2021. Methods: This cross sectional study was conducted during a period of 6 months (From September 1, 2021 to February 31, 2022) on 102 patients admitted to Shahid Chamran Hospital in Isfahan City. Patient information such as demographic information, indication and dosages of drugs, the basis of drug prescription, side effects and drug interactions, etc. were extracted from the medical records of patients and hospital systems and recorded in designed forms. After matching the information with the relevant guidelines, statistical analysis was performed using SPSS-16 software. Results: Out of the 102 patients, who received linezolid, 75.1% were men and the rest were women. 99% of the cases were prescribed experimentally and 1% was based on culture. In 40.2% of the patients, drugs were prescribed irrationally in terms of prescription indications. In 84.3% of the cases, a change in treatment regimen was observed after receiving the culture results. Conclusion: A large percentage of cases of linezolid drug prescription was not done correctly. Furthermore, it has not been attention to the side effects caused by the drug, especially thrombocytopenia.","PeriodicalId":17084,"journal":{"name":"Journal of Shahid Sadoughi University of Medical Sciences","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Shahid Sadoughi University of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ssu.v31i9.14186","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The rational use of drugs is one of the main elements of achieving the best pharmacotherapy method for patients. Linezolid is used for infections caused by gram-positive bacteria, including vancomycin-resistant staphylococci and vancomycin-resistant enterococci, but the inappropriate use of this drug has led to the emergence of linezolid-resistant strains. The purpose of this study was to investigate the manner of Linezolid prescription in Shahid Chamran Hospital of Isfahan City in 2021. Methods: This cross sectional study was conducted during a period of 6 months (From September 1, 2021 to February 31, 2022) on 102 patients admitted to Shahid Chamran Hospital in Isfahan City. Patient information such as demographic information, indication and dosages of drugs, the basis of drug prescription, side effects and drug interactions, etc. were extracted from the medical records of patients and hospital systems and recorded in designed forms. After matching the information with the relevant guidelines, statistical analysis was performed using SPSS-16 software. Results: Out of the 102 patients, who received linezolid, 75.1% were men and the rest were women. 99% of the cases were prescribed experimentally and 1% was based on culture. In 40.2% of the patients, drugs were prescribed irrationally in terms of prescription indications. In 84.3% of the cases, a change in treatment regimen was observed after receiving the culture results. Conclusion: A large percentage of cases of linezolid drug prescription was not done correctly. Furthermore, it has not been attention to the side effects caused by the drug, especially thrombocytopenia.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
伊斯法罕市 Shahid Chamran 医院在 2021 年后六个月对住院患者合理使用利奈唑胺的评估
导言:合理用药是为患者实现最佳药物治疗方法的主要因素之一。利奈唑胺用于治疗革兰氏阳性菌(包括耐万古霉素葡萄球菌和耐万古霉素肠球菌)引起的感染,但该药物的不当使用导致了耐利奈唑胺菌株的出现。本研究旨在调查伊斯法罕市沙希德-查姆兰医院 2021 年利奈唑胺处方的使用方式。 研究方法这项横断面研究为期 6 个月(2021 年 9 月 1 日至 2022 年 2 月 31 日),对象是伊斯法罕市 Shahid Chamran 医院的 102 名住院患者。从患者病历和医院系统中提取了患者信息,如人口统计学信息、药物适应症和剂量、药物处方依据、副作用和药物相互作用等,并记录在设计好的表格中。将这些信息与相关指南进行比对后,使用 SPSS-16 软件进行统计分析。 结果在 102 例接受利奈唑胺治疗的患者中,75.1% 为男性,其余为女性。99%的病例是实验性处方,1%是根据培养结果处方。40.2%的患者在处方适应症方面用药不合理。84.3%的病例在收到培养结果后改变了治疗方案。 结论很大比例的利奈唑胺处方用药不正确。此外,也没有注意到该药物引起的副作用,尤其是血小板减少症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Damages of Freezing on the Development of Oocyte and Embryos Parental Acceptance of Dental Treatment Options for Primary Teeth Comparative Evaluation of Severity of Periodontitis in Patients with and without Dyssomnias Serum Resistin Levels in Patients with Nonalcoholic Fatty Liver Disease in an Iranian Population Evaluation of the Personality Characteristics of Cardiovascular Patients and People with a History of Drug abuse with the Control Group
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1